Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - doxycycline hyclate, quantity: 57.7 mg (equivalent: doxycycline, qty 50 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; maize starch; colloidal anhydrous silica; magnesium stearate; titanium dioxide; hypromellose; indigo carmine; macrogol 4000 - infections caused by the following microorganisms: mycoplasma pneumoniae (primary atypical pneumonia); rickettsiae (queensland tick typhus, epidemic typhus fever, q fever, murine endemic typhus fever, australo-pacific endemic scrub typhus): chlamydia psittaci (psittacosis); chlamydia trachomatis (lymphogranuloma venereum, trachoma, inclusion conjunctivitis). (doxycycline is indicated in the treatment of trachoma, although the infectious agent is not always eliminated, as judged by immunofluorescence. inclusion conjunctivitis may be treated with oral doxycycline alone or in combination with topical agents). borreliae (relapsing fever); calymmatobacterium (donovania) granulomatis (granuloma inguinale). infections caused by the following gram-negative microorganisms: vibrio sp. (cholera); brucella sp. (brucellosis, in conjunction with streptomycin); haemophilus ducreyi (chancroid); yersinia pestis (plague); francisella tularensis (tularaemia); bartonella bacilliformis (bartonellosis); bacteroides sp. when penicillin is contraindicated, doxycycline is an alternative drug in the treatment of infections due to: treponema pallidum (syphilis); treponema perenue (yaws); neisseria gonorrhoea (see dosage and administration). doxycycline is not the drug of choice in the treatment of any type of staphylococcal infection of infections caused by streptococcus pneumoniae, haemophilus influenzae, streptococcus pyogenes, enterococcus faecalis or any type of enteric bacteria because many strains of these organisms have been shown to be resistant to doxycycline. doxycycline should not be used in these infections unless the organism has been shown to be sensitive. for upper respiratory infections due to group a b-haemolytic streptococci (including prophylaxis of rheumatic fever), penicillin is the usual drug of choice. in acute intestinal amoebiasis doxycycline may be a useful adjunct to amoebicides. in severe acne, doxycycline may be a useful adjunctive therapy. doxycycline is indicated, in adults and children older than 10 years, as chemoprophylaxis for malaria caused by plasmodium falciparum and, in combination with other antimalarial agents, against malaria caused by plasmodium vivax. doxycycline is only able to suppress malaria caused by p. vivax. as there are relatively few locations where p. vivax does not co-exist to some extent with p. falciparum, it is recommended that doxycycline should be used routinely with other agents, for example chloroquine. note: the 50mg tablet is not a paediatric formulation.

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

heritage pharmaceuticals inc. d/b/a avet pharmaceuticals inc. - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - doxycycline anhydrous 75 mg - doxycycline hyclate delayed-release tablets are indicated for treatment of rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox, and tick fevers caused by rickettsiae. doxycycline hyclate delayed-release tablets are indicated for treatment of the following sexually transmitted infections: • uncomplicated urethral, endocervical or rectal infections caused by chlamydia trachomatis . • nongonococcal urethritis caused by ureaplasma urealyticum . • lymphogranuloma venereum caused by chlamydia trachomatis . • granuloma inguinale caused by klebsiella granulomatis . • uncomplicated gonorrhea caused by neisseria gonorrhoeae . • chancroid caused by haemophilus ducreyi . doxycycline hyclate delayed-release tablets are indicated for treatment of the following respiratory infections: • respiratory tract infections caused by mycoplasma pneumoniae . psittacosis (ornithosis) caused by chlamydophila psittaci . • because many strains of the following groups of microorganisms have bee

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

mayne pharma commercial llc - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - doxycycline anhydrous 75 mg - doxycycline hyclate delayed-release tablets are indicated for treatment of rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox, and tick fevers caused by rickettsiae . doxycycline hyclate delayed-release tablets are indicated for treatment of the following sexually transmitted infections: - uncomplicated urethral, endocervical or rectal infections caused by chlamydia trachomatis. - nongonococcal urethritis caused by ureaplasma urealyticum . - lymphogranuloma venereum caused by chlamydia trachomatis . - granuloma inguinale caused by klebsiella granulomatis . - uncomplicated gonorrhea caused by neisseria gonorrhoeae. - chancroid caused by haemophilus ducreyi . doxycycline hyclate delayed-release tablets are indicated for treatment of the following respiratory infections: - respiratory tract infections caused by mycoplasma pneumoniae . psittacosis (ornithosis) caused by chlamydophila psittaci . - because many strains of the following groups of microorganisms have been shown t

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

mayne pharma commercial llc - doxycycline hyclate (unii: 19xts3t51u) (doxycycline anhydrous - unii:334895s862) - doxycycline anhydrous 50 mg - doxycycline hyclate delayed-release tablets are indicated for treatment of rocky mountain spotted fever, typhus fever and the typhus group, q fever, rickettsialpox, and tick fevers caused by rickettsiae . doxycycline hyclate delayed-release tablets are indicated for treatment of the following sexually transmitted infections: - uncomplicated urethral, endocervical or rectal infections caused by chlamydia trachomatis. - nongonococcal urethritis caused by ureaplasma urealyticum . - lymphogranuloma venereum caused by chlamydia trachomatis . - granuloma inguinale caused by klebsiella granulomatis . - uncomplicated gonorrhea caused by neisseria gonorrhoeae. - chancroid caused by haemophilus ducreyi . doxycycline hyclate delayed-release tablets are indicated for treatment of the following respiratory infections: - respiratory tract infections caused by mycoplasma pneumoniae . psittacosis (ornithosis) caused by chlamydophila psittaci . - because many strains of the following groups of microorganisms have been shown t

Nīderlande - holandiešu - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

pantex holland b.v. - doxycyclinehyclaat; doxycycline 0-water - poeder voor gebruik in drinkwater - doxycyclinehyclaat 500 mg/g; doxycycline 0-water 433 mg/g, - doxycycline

Beļģija - vācu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratoires sterop - phenobarbital-natrium - injektionslösung - 40 mg/1 ml - phenobarbital-natrium 40 mg/ml - phenobarbital

Beļģija - vācu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratoires sterop - phenobarbital-natrium - injektionslösung - 200 mg/2 ml - phenobarbital-natrium 100 mg/ml - phenobarbital

Īrija - angļu - HPRA (Health Products Regulatory Authority)

le vet bv - phenobarbital - tablet - 100 mg/tablet - phenobarbital - dogs - neurological preparations

Kanāda - angļu - Health Canada

pfizer canada ulc - doxycycline (doxycycline hyclate) - capsule - 100mg - doxycycline (doxycycline hyclate) 100mg - tetracyclines

Kanāda - angļu - Health Canada

apotex inc - doxycycline (doxycycline hyclate) - capsule - 100mg - doxycycline (doxycycline hyclate) 100mg - tetracyclines